Literature DB >> 17488251

Extensive gastric atrophy: an increased risk factor for superficial esophageal squamous cell carcinoma in Japan.

Katsunori Iijima1, Tomoyuk Koike, Yasuhiko Abe, Yoshifumi Inomata, Hitoshi Sekine, Akira Imatani, Naoki Nakaya, Shuichi Ohara, Tooru Shimosegawa.   

Abstract

OBJECTIVES: A recent study in Sweden has reported that gastric atrophy is associated with an increased risk for esophageal squamous cell carcinoma. However, this finding needs to be confirmed in other ethnic groups due to the wide geographic variation of this cancer.
OBJECTIVES: To investigate whether gastric atrophy is associated with a risk for esophageal squamous cell carcinoma using a case-control study in Japanese subjects, a population known to have a high prevalence of H. pylori infection and accompanying gastric atrophy.
METHODS: Seventy-three patients who had undergone endoscopic mucosal resection for superficial esophageal squamous cell carcinoma, and 73 sex- and age-matched controls, were enrolled prospectively. Gastric fundic atrophy was evaluated by histology of biopsy specimens and serum pepsinogen I level (cutoff level 25 ng/mL). Conditional logistic regression model with adjustment for potential confounding factors was used to assess the associations.
RESULTS: Gastric atrophy, defined histologically or serologically, was independently associated with an increased risk for esophageal squamous cell carcinoma and the risk seemed to increase with the progression of the atrophy. Multivariate odds ratio (95% confidence interval) for histological fundic atropy, fundic intestinal metaplasia, and serological atrophy are 4.2 (1.5-11.7), 10.7 (2.3-50.4), and 8.2 (2.2-30.4), respectively.
CONCLUSIONS: Gastric atrophy, a newly recognized risk factor for esophageal squamous cell carcinoma in Sweden, is likely to be a risk factor in other areas. Further studies are warranted to explore the causal relationship.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488251     DOI: 10.1111/j.1572-0241.2007.01257.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

1.  Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.

Authors:  Michael B Cook; Sanford M Dawsey; Lena Diaw; Martin J Blaser; Guillermo I Perez-Perez; Christian C Abnet; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Helicobacter pylori and esophageal cancer risk: a meta-analysis.

Authors:  Farhad Islami; Farin Kamangar
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

3.  Serum ghrelin is inversely associated with risk of subsequent oesophageal squamous cell carcinoma.

Authors:  Gwen Murphy; Farin Kamangar; Demetrius Albanes; Frank Z Stanczyk; Stephanie J Weinstein; Philip R Taylor; Jarmo Virtamo; Christian C Abnet; Sanford M Dawsey; Neal D Freedman
Journal:  Gut       Date:  2011-12-16       Impact factor: 23.059

4.  Incidence of esophageal carcinoma among Malays in North-Eastern Peninsular Malaysia: an area with an exceptionally low prevalence of Helicobacter pylori infection.

Authors:  Yeong Yeh Lee; S Mahendra Raj; Sharifah Emilia Tuan Sharif; Rosemi Salleh; Mukarramah Che Ayub; David Y Graham
Journal:  Dig Dis Sci       Date:  2010-11-17       Impact factor: 3.199

5.  Gastric hyposecretion in esophageal squamous-cell carcinomas.

Authors:  K Iijima; T Koike; Y Abe; H Yamagishi; N Ara; K Asanuma; K Uno; A Imatani; N Nakaya; S Ohara; T Shimosegawa
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

Review 6.  Environmental causes of esophageal cancer.

Authors:  Farin Kamangar; Wong-Ho Chow; Christian C Abnet; Sanford M Dawsey
Journal:  Gastroenterol Clin North Am       Date:  2009-03       Impact factor: 3.806

7.  Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort.

Authors:  J-S Ren; F Kamangar; Y-L Qiao; P R Taylor; H Liang; S M Dawsey; B Liu; J-H Fan; C C Abnet
Journal:  Gut       Date:  2009-01-09       Impact factor: 23.059

8.  Serum pepsinogens and risk of esophageal squamous dysplasia.

Authors:  Farin Kamangar; Lena Diaw; Wen-Qiang Wei; Christian C Abnet; Guo-Qing Wang; Mark J Roth; Bing Liu; Ning Lu; Carol Giffen; You-Lin Qiao; Sanford M Dawsey
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

Review 9.  Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis.

Authors:  Fa-Jun Xie; Yi-Ping Zhang; Qiu-Qing Zheng; Hong-Chuan Jin; Fa-Liang Wang; Ming Chen; Lan Shao; De-Hong Zou; Xin-Min Yu; Wei-Min Mao
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

10.  A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.

Authors:  Tomoo Yamazaki; Yugo Iwaya; Mai Iwaya; Takayuki Watanabe; Ayako Seki; Yasuhide Ochi; Etsuo Hara; Tomohiro Sekiguchi; Noriko Hosaka; Norikazu Arakura; Eiji Tanaka; Osamu Hasebe
Journal:  Clin J Gastroenterol       Date:  2016-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.